Grayish discoloration of the face - Argyria;Szürke arcszín - Argyria

Orvosi Hetilap

Volumn 150, Issue 32, 2009, Pages 1503-1507

  Tóth, Veronika ^a,b   Marschalkó, Márta ^a   Hársing, Judit ^a   Kárpáti, Sarolta ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b NONE   (Hungary)

Author keywords

Argyria; Colloidal silver; Gray discoloration of the skin; Paramedicine

Indexed keywords

SILVER CHLORIDE;

ADULT; ARGYRIA; CASE REPORT; FACE; FINGER NAIL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNE SYSTEM; LABORATORY TEST; MALE; MOUTH MUCOSA; REVIEW; VEGETARIAN;

EID: 68549107798     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: 10.1556/OH.2009.28682     Document Type: Review

References (56)

1. Wadhera, A., Fung, M.: Systemic argyria associated with ingestion of colloidal silver. Dermatol. Online J., 2005, 11, 12.
2. Rackoff, E. M., Benbenisty, K. M., Maize, J. C. és mtsa: Localized cutaneous argyria from an acupuncture needle clinically concerning for metastatic melanoma. Cutis, 2007, 80, 423-426.
3. Jańczuk, Z., Banach, J.: Local argyrosis of oral mucosa or amalgam tattoo. A problem in diagnosis and treatment. Adv. Med. Sci., 2006, 51, 62-65.
4. Hendricks, W. M.: Complications of ear piercing: treatment and prevention. Cutis, 1991, 48, 386-394.
5. Jensen, S. T.: Argyrosis of conjunctiva in studio photographer.Acta Ophthalmol., 1962, 40, 544-547.
6. Lansdown, A. B.: Silver in health care: antimicrobial effects and safety in use. Curr. Probl. Dermatol., 2006, 33, 17-34.
7. Mirsattari, S. M., Hammond, R. R., Sharpe, M. D. és mtsai: Myo- clonic status epilepticus following repeated oral ingestion of colloidal silver. Neurology, 2004, 62, 1408-1410.
8. Zografos, L., Uffer, S., Chamot, L.: Unilateral conjunctival-cor- neal argyrosis stimulating conjunctival melanoma. Arch. Ophtal-mol., 2003, 121, 1483-1487.
9. Rossmann, P., Ríha, I., Starý, V.: Detection of cationic and non- cationic markers in the rat glomerulus by electron probe analysis. Virchows Arch. B Cell Pathol. Incl. Mol. Pathol., 1989, 57, 329-337.
10. Matzinger, M. A., Gray, R. R., Leekam, R. N. és mtsai: Argyrosis of the urinary tract. Journal of Clinical Ultrasound, 1985, 13, 288-290.
11. Baker, C. D., Federico, M. J., Accurso, F. J.: Case report: skin discoloration following administration of colloidal silver in cystic fibrosis. Curr. Opin. Pediatr., 2007, 19, 733-735.
12. Kim, Y., Suh, H. S., Cha, H. J. és mtsai: A case of generalized argyria after ingestion of colloidal silver solution. Am. J. Ind. Med., 2009, 52, 246-250.
13. Chang, A. L., Khosravi, V., Egbert, B.: A case of argyria after colloidal silver ingestion. J. Cutan Pathol., 2006, 33, 809-811.
14. Baker, C. D., Federico, M. J., Accurso, F. J.: Case report: skin discoloration following administration of colloidal silver in cystic fibrosis. Curr. Opin. Pediatr., 2007, 19, 733-735.
15. Kalouche, H., Watson, A., Routley, D.: Blue lunulae: argyria and hypercopprecaemia. Australas. J. Dermatol., 2007, 48, 182-184.
16. Rhee, D. Y., Chang, S. E., Lee, M. W. és mtsai: Treatment of argyria after colloidal silver ingestion using Q-switched 1,064-nm Nd:YAG laser. Dermatol. Surg., 2008, 34, 1427-1430.
17. ÁNTSZ Országos Tisztiforvosi Hivatal Közegé szségügyi F"oztály OTH 5180-4/2008 iktató számú határozata.
18. http://www.biodepo.hu/product-info.php?products-id=138/
19. http://shop.unas.hu/shop-art.php?shop-id=5014&cat= 205866/
20. Jónás J.: A pulmonológiai intézmények 2007. évi epidemiológiai és mu"ködési adatai. Országos Korányi Tbc és Pulmonológiai Intézet, 2008.
21. Holguin, F., Folch, E., Redd, S. C. és mtsa: Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001. Chest, 2005, 128, 2005-2011.
22. Rabe, K. F., Hurd, S., Anzueto, A és mtsai: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am. J. Respir. Crit. Care Med., 2007, 176, 532-555.
23. WHO: Adherence to long-term therapies: evidence for action. World Health Organization, 2003, 1-59.
24. Regueiro, C. R., Hamel, M. B., Davis, R. B. és mtsai: A comparison of generalist and pulmonologist care for patients hospitalized with severe chronic obstructive pulmonary disease: Resource intensity, hospital costs, and survival. American Journal of Medicine, 1998, 105, 366-372.
25. Bourbeau, J., Bartlett, S. J.: Patient adherence in COPD. Thorax, 2008, 63, 831-838.
26. Seemungal, T. A R., Donaldson, G. C., Paul, E. A. és mtsai: Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med., 1998, 157, 1418-1422.
27. Koncz T.: A beteg együttmu"ködés egészség-gazdaságtani jelento"sége. In Egészség-gazdaságtan. Szerk.: Gulácsi L. Medicina Könyvkiadó, 2005, 401-435.
28. Haynes, R. B., Montague, P., Oliver, T. és mtsai: Interventions for helping patients to follow prescriptions for medications. Cochrane Database Syst. Rev., 2000, 2.
29. Cleemput, I., Kesteloot, K., DeGeest, S.: A review of the literature on the economics of noncompliance. Room for methodological improvement. Health Policy, 2002, 59, 65-94.
30. Cramer, J. A., Roy, A., Burrell, A. és mtsai: Medication compliance and persistence: Terminology and definitions. Value in Health, 2008, 11, 44-47.
31. Peterson, A. M., Nau, D. P., Cramer, J. A. és mtsai: A checklist for medication compliance and persistence studies using retrospective databases. Value in Health, 2007, 10, 3-12.
32. Kennedy, J., Tuleu, I., Mackay, K.: Unfilled prescriptions of medicare beneficiaries: Prevalence, reasons, and types of medicines prescribed. Journal of Managed Care Pharmacy, 2008, 14, 553-560.
33. Breekveldt-Postma, N. S., Gerrits, C. M. J. M., Lammers, J. W. J. és mtsai: Persistence with inhaled corticosteroid therapy in daily practice. Respir. Med., 2004, 98, 752-759.
34. Jung, E., Pickard, A. S., Salmon, J. W. és mtsai: Medication adherence and persistence in the last year of life in COPD patients. Respir. Med., 2009, 103, 525-534.
35. Cramer, J. A., Benedict, A., Muszbek, N. és mtsai: The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: A review. Int. J. Clin. Pract., 2008, 62, 76-87.
36. Breekveldt-Postma, N. S., Koerselman, J., Erkens, J. A. és mtsai: Enhanced persistence with tiotropium compared with other respiratory drugs in COPD. Respir. Med., 2007, 101, 1398-1405.
37. Cramer, J. A., Bradley-Kennedy, C., Scalera, A.: Treatment persistence and compliance with medications for chronic obstructive pulmonary disease. Can. Respir. J., 2007, 14, 25-29.
38. Restrepo, R. D., Alvarez, M. T., Wittnebel, L. D. és mtsai: Medication adherence issues in patients treated for COPD. Int. J. Chron. Obstruct. Pulmon. Dis., 2008, 3, 371-384.
39. Krigsman, K., Moen, J., Nilsson, J. L. G. és mtsa: Refill adherence by the elderly for asthma/chronic obstructive pulmonary disease drugs dispensed over a 10-year period. Journal of Clinical Pharmacy and Therapeutics, 2007, 32, 603-611.
40. Krigsman, K., Nilsson, J. L. G., Ring, L.: Refill adherence for patients with asthma and COPD: Comparison of a pharmacy record database with manually collected repeat prescriptions. Pharmacoepidemiology and Drug Safety, 2007, 16, 441-448.
41. Yeo, J., Karimova, G., Bansal, S.: Co-morbidity in older patients with COPD - Its impact on health service utilisation and quality of life, a community study. Age and Ageing, 2006, 35, 33-37.
42. Krigsman, K., Nilsson, J. L. G., Ring, L.: Adherence to multiple drug therapies: Refill adherence to concomitant use of diabetes and asthma/COPD medication. Pharmacoepidemiology and Drug Safety, 2007, 16, 1120-1128.
43. Corden, Z. M., Bosley, C. M., Rees, P. J. és mtsai: Home nebulized therapy for patients with COPD: Patient compliance with treatment and its relation to quality of life. Chest, 1997, 112, 1278-1282.
44. George, J., Kong, D. C. M., Thoman, R. és mtsa: Factors associated with medication nonadherence in patients with COPD. Chest, 2005, 128, 3198-3204.
45. Rand, C. S.: Patient adherence with COPD therapy. European Respiratory Review, 2005, 14, 97-101.
46. Van Manen, J. G., Bindels, P. J. E., Dekker, F. W. és mtsai: Risk of depression in patients with chronic obstructive pulmonary disease and its determinants. Thorax, 2002, 57, 412-416.
47. Apter, A. J., Reisine, S. T., Affleck, G. és mtsai: Adherence with twice-daily dosing of inhaled steroids: Socioeconomic and health- belief differences. Am. J. Respir. Crit. Care Med., 1998, 157, 1810-1817.
48. Chambers, C. V., Markson, L., Diamond, J. J. és mtsai: Health beliefs and compliance with inhaled corticosteroids by asthmatic patients in primary care practices. Respiratory Medicine, 1999, 93, 88-94.
49. Dimatteo, M. R.: Psychology of health illness and medical care: An individual perspective. Thomson Brooks/Cole, 1991.
50. Onyirimba, F., Apter, A., Reisine, S. és mtsai: Direct clinician-to- patient feedback discussion of inhaled steroid use: Its effect on adherence. Annals of Allergy, Asthma and Immunology, 2003, 90, 411-415.
51. Bailey, W. C., Richards, J. M. Jr., Brooks, C. M. és mtsai: A randomized trial to improve self-management practices of adults with asthma. Arch. Intern. Med., 1990, 150, 1664-1668.
52. Put, C., Van den Bergh, O., Lemaigre, V. és mtsai: Evaluation of an individualised asthma programme directed at behavioural change. Eur. Respir. J., 2003, 21, 109-115.
53. Hesselink, A. E., Penninx, B. W. J. H., Van Der Windt, D. A. W. M. és mtsai: Effectiveness of an education programme by a general practice assistant for asthma and COPD patients: Results from a randomised controlled trial. Patient Educ. Couns., 2004, 55, 121-128.
54. Gallefoss, F.: The effects of patient education in COPD in a 1-year follow-up randomised, controlled trial. Patient Education and Counseling, 2004, 52, 259-266.
55. Worth, H., Dhein, Y.: Does patient education modify behaviour in the management of COPD? Patient Education and Counseling, 2004, 52, 267-270.
56. Petrilla, A. A., Benner, J. S.: Critical evaluation of interventions to enhance patient compliance with chronic medications. Value in Health, 2003, 6, 200.